Ali Samii is a Neurology physician affiliated with University of Washington Medical Center. OpenAlex indexes 162 publications with 16,983 citations (h-index 59). By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Washington Medical Ctr
1959 NE Pacific St
Seattle, WA 981950001
Telephone
206-598-5068Registry record last updated 21 Nov 2012.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Amneal Pharmaceuticals LLCProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
93.7%Aromatic Amino Acid Decarboxylation Inhibitor58.8%Carbidopa-Levodopa53%Carbidopa-Levodopa Er41%Rytary6%Part D<11 patientsNonergot Dopamine Agonist9.7%Pramipexole Dihydrochloride67%Ropinirole Hcl33%Part D<11 patients+ 6 more classes in this area
Cardiovascular
6.3%Beta blocker6.3%Propranolol Hcl66%Propranolol Hcl Er34%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Electroconvulsive Therapy for Depression in Parkinson’s Disease: Systematic Review of Evidence and Recommendations
Neurodegenerative Disease Management
2016 - The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease
Molecular Neurodegeneration
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Ganesh Raghu, MD
University of Washington Medical Center
Mark Wener
University of Washington Medical Center
Creighton Don, MD, PhD
University of Washington Medical Center
Peter Leary, MD
University of Washington Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”